» Articles » PMID: 2840658

Overcoming Interference to Retroviral Superinfection Results in Amplified Expression and Transmission of Cloned Genes

Overview
Specialty Science
Date 1988 Aug 1
PMID 2840658
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

A procedure is described for stably expressing cloned genes at high levels in vertebrate cells and for obtaining these genes in high-titer virus preparations. The process uses retroviral vectors and mixtures of two "packaging cell lines" that incorporate retroviral genomes into virions with different host-range envelopes. In these cocultures, interference barriers to superinfection are overcome, retroviral vectors can replicate in the absence of a transmissible helper virus, and the cells become infected with multiple copies of the provirus that contains the cloned gene. This procedure was used to amplify expression of the membrane glycoprotein that is encoded by Friend spleen focus-forming virus, a retrovirus that is replication defective in other cell cultures. Amplifications were measured at the DNA provirus, RNA, and protein levels. In addition, the human growth hormone gene was inserted into retroviral vectors and we observed amplifications of growth hormone synthesis and secretion. The amplified growth hormone was properly processed as indicated by immunoblot analyses. A vector is described (pSFF) that is exceptionally active in coculture amplification.

Citing Articles

Engineering T cell function using chimeric antigen receptors identified using a DNA library approach.

Duong C, Westwood J, Yong C, Murphy A, Devaud C, John L PLoS One. 2013; 8(5):e63037.

PMID: 23667569 PMC: 3646939. DOI: 10.1371/journal.pone.0063037.


Effect of hydrophobic mutations in the H2-H3 subdomain of prion protein on stability and conversion in vitro and in vivo.

Hafner-Bratkovic I, Gaedtke L, Ondracka A, Veranic P, Vorberg I, Jerala R PLoS One. 2011; 6(9):e24238.

PMID: 21909425 PMC: 3164720. DOI: 10.1371/journal.pone.0024238.


Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.

Hafner-Bratkovic I, Bester R, Pristovsek P, Gaedtke L, Veranic P, Gaspersic J J Biol Chem. 2011; 286(14):12149-56.

PMID: 21324909 PMC: 3069419. DOI: 10.1074/jbc.M110.213926.


Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1.

Platt E, Bilska M, Kozak S, Kabat D, Montefiori D J Virol. 2009; 83(16):8289-92.

PMID: 19474095 PMC: 2715758. DOI: 10.1128/JVI.00709-09.


A murine leukemia virus with Cre-LoxP excisible coding sequences allowing superinfection, transgene delivery, and generation of host genomic deletions.

Wang C, Hodgson J, Malek T, Pedersen F, Wabl M Retrovirology. 2004; 1:5.

PMID: 15169571 PMC: 419723. DOI: 10.1186/1742-4690-1-5.


References
1.
STECK F, Rubin H . The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. Virology. 1966; 29(4):628-41. DOI: 10.1016/0042-6822(66)90287-x. View

2.
Palmer T, Hock R, Osborne W, Miller A . Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci U S A. 1987; 84(4):1055-9. PMC: 304360. DOI: 10.1073/pnas.84.4.1055. View

3.
Delarco J, Todaro G . Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell. 1976; 8(3):365-71. DOI: 10.1016/0092-8674(76)90148-3. View

4.
Jamjoom G, Naso R, Arlinghaus R . Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol. 1976; 19(3):1054-72. PMC: 354946. DOI: 10.1128/JVI.19.3.1054-1072.1976. View

5.
Gusella J, Geller R, Clarke B, Weeks V, Housman D . Commitment to erythroid differentiation by friend erythroleukemia cells: a stochastic analysis. Cell. 1976; 9(2):221-9. DOI: 10.1016/0092-8674(76)90113-6. View